Osteoporosis is described as a silent disease because bone loss produces no symptoms until a fracture occurs. By the time a woman learns she has significantly reduced bone density, the loss may have been accumulating for years.
This silence makes it easy to deprioritize. Hot flashes demand attention. Sleep disruption is impossible to ignore. Bone density is invisible... But of all the long-term health consequences of the menopause transition, accelerated bone loss is among the most significant and the most preventable, if addressed during the right window.
Throughout life, bone tissue is continuously broken down and rebuilt through a process called remodeling. Specialized cells called osteoclasts resorb old bone; osteoblasts form new bone to replace it. In healthy adults, this process is roughly balanced.
Estrogen plays a critical role in this balance. It suppresses osteoclast activity, slowing bone resorption. When estrogen declines at menopause, the brake on bone resorption is released. Osteoclast activity increases while osteoblast activity does not increase proportionally, tipping the balance toward net bone loss.
The rate of loss is steepest in the first few years after menopause. Research indicates that women can lose between 1 and 3 percent of bone mineral density per year in the early postmenopausal period, compared to less than 1 percent per year before menopause. Over five to seven years, this compounds to a meaningful reduction in structural integrity.
The bones most vulnerable to this accelerated loss are the trabecular bone-rich sites: the lumbar spine, the hip, and the distal forearm. These are also the sites of the most clinically significant osteoporotic fractures.
Osteoporosis is defined by bone mineral density measurement, typically reported as a T-score from a DEXA scan.
One in two women over 50 will experience an osteoporosis-related fracture in her lifetime. Hip fractures are the most serious consequence: approximately 20 percent of people who sustain a hip fracture die within one year, and many who survive experience permanent loss of independence.
Vertebral fractures are more common than hip fractures and are often not diagnosed because they may cause only mild or unrecognized back pain. They contribute to height loss and the progressive spinal curvature seen in older women, but they also significantly increase the risk of subsequent fractures.
While menopause is a universal risk factor for accelerated bone loss, some women are at considerably higher risk than others. Additional risk factors include:
Estrogen therapy is one of the most effective interventions available for preventing postmenopausal bone loss. Multiple studies have confirmed that hormone therapy significantly reduces the rate of bone loss, maintains or increases bone mineral density at the spine and hip, and reduces fracture risk.
The timing of intervention matters. Starting hormone therapy in early menopause, when bone loss is most rapid, provides the greatest protective benefit. Bone density gains from HRT are largely reversed when therapy is discontinued, which means that the decision about duration of treatment should factor in bone health alongside other considerations.
For women who are not candidates for systemic hormone therapy, local estrogen therapy does not provide meaningful systemic bone protection. Other pharmacological options exist and are indicated for women with established osteoporosis or very high fracture risk.
Calcium is the primary mineral component of bone. Adequate calcium intake is necessary but not sufficient for bone health: calcium alone does not prevent menopause-related bone loss, but deficiency accelerates it.
The recommended daily calcium intake for postmenopausal women is 1,200 mg per day, with food sources preferred over supplements where possible. The evidence for calcium supplements specifically has become more nuanced in recent years, with some studies raising questions about cardiovascular risk at high supplemental doses. Getting calcium primarily from food remains the preferred approach.
High-calcium food sources include dairy products, fortified plant milks, canned fish with bones (sardines, salmon), tofu made with calcium sulphate, almonds, and dark leafy greens including kale and bok choy.
Vitamin D is essential for calcium absorption. Deficiency is common, particularly in northern latitudes and in women who spend limited time outdoors. The recommended daily intake for women over 50 is 800 to 1,000 IU, with many experts recommending higher amounts for those with confirmed deficiency. A blood test is the appropriate way to assess status.
As covered in the article on strength training, bone is a mechanically responsive tissue. Resistance training and weight-bearing impact exercise stimulate bone formation at the sites being loaded.
A systematic review and meta-analysis found that combined resistance and impact exercise programs produced significant improvements in spine and hip bone mineral density in postmenopausal women. The effect was most pronounced when programs included progressive resistance training alongside moderate-impact activities such as jumping or step exercises.
Non-weight-bearing exercise such as swimming and cycling, while valuable for cardiovascular health, does not provide meaningful bone-loading stimulus. Women who exercise primarily in water or on a bike should ensure they are also doing land-based resistance and impact work.
Bone is approximately 30 percent protein by composition. Adequate protein intake supports the collagen matrix that gives bone its flexibility and fracture resistance. Low protein intake is associated with lower bone mineral density and higher fracture risk in older adults.
A DEXA scan is the standard clinical tool for measuring bone mineral density. Current guidelines recommend bone density screening for all women aged 65 and older, and for younger postmenopausal women with additional risk factors.
Women who experienced early menopause, have used long-term corticosteroids, have a family history of osteoporosis, or have other significant risk factors should discuss the timing of their first DEXA scan with a clinician rather than waiting until 65.
A baseline scan in early menopause, when bone loss is most rapid, allows for monitoring of change over time and provides information that can meaningfully inform decisions about hormone therapy duration and other interventions.
The years immediately surrounding menopause represent both the period of greatest bone loss and the period when intervention has the greatest impact. This is not a coincidence. The biology of bone remodeling means that the interventions most effective at preserving bone density work best when the resorption rate is highest, because they are targeting the accelerated osteoclast activity that estrogen loss has unleashed.
Bone health in menopause is not a conversation to defer until a fracture happens or a scan reveals significant loss. The evidence is clear that the time to act is during the transition, with a combination of appropriate hormonal management, nutrition, and the right kind of exercise. All three together produce outcomes that none achieves alone.
Sources
Weaver AA, Tooze JA, Cauley JA, et al. Effect of dietary protein intake on bone mineral density and fracture incidence in older adults: the Health, Aging, and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2021
Massini DA, Nedog FH, de Oliveira TP, et al. The effect of resistance training on bone mineral density in older adults: a systematic review and meta-analysis. Healthcare (Basel). 2022
van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002
Cauley JA et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA. 2003.
Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; 2011.
Sahni S et al. Higher protein intake is associated with higher lean mass and quadriceps muscle strength in adult men and women. J Nutr. 2015.
U.S. Preventive Services Task Force. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA. 2025
This article is for informational purposes only and is not medical advice. Always consult a qualified clinician to discuss your health and treatment options.
Hemma Wellness is not a medical practice. All clinical services are provided by licensed healthcare professionals through our partner network. Individual results may vary.
These statements have not been evaluated by the Food and Drug Administration. Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality. This content is intended for informational purposes only and does not constitute medical advice.
Labs are billed separately when ordered by your clinician, except where noted in specific program descriptions.
